review · Medicine
Diabetes significantly affects cognitive function, spanning from mild cognitive impairment to vascular dementia and Alzheimer disease. This relationship is complex and frequently compounded by common comorbidities such as hypertension and dyslipidaemia. Current clinical and research practices face notable challenges, particularly the absence of standardised diagnostic paradigms and limited insight into cognitive outcomes across different diabetes types and younger demographics. Addressing these challenges requires an interdisciplinary framework combining endocrinology, neuroscience, and immunology to decipher the underlying biological mechanisms. Prospective research priorities centre on longitudinal investigations to track disease progression and pinpoint critical windows of vulnerability. Crucially, discovering accurate predictive factors and biomarkers, encompassing genetic and epigenetic profiles, is essential to design personalised interventions that cater to the considerable variability in cognitive decline observed among individuals living with diabetes.
Diabetes is increasingly prevalent worldwide, and its link to severe cognitive decline creates an expanding public health challenge. Clarifying how metabolic disorders impair brain function allows for earlier identification of at-risk patients. Developing standardised diagnostic standards and tailored treatment strategies will help healthcare systems curb long-term neurological damage, preserve personal independence, and enhance the quality of life for individuals living with chronic metabolic disease.
The findings represent an early, conceptual stage of research. Potential applications centre on future diagnostic tools, prognostic biomarkers, and targeted therapeutics for healthcare providers and diagnostic developers managing diabetes-related neurodegeneration. Because the findings outline research gaps and the need for prospective discovery rather than a tested product or prototype, commercial deployment remains distant and requires extensive primary validation before practical clinical tools can emerge.
AI-generated from the published abstract. Always read the original work before citing.
Cognitive impairment in individuals with diabetes represents a multifaceted and increasingly prevalent health concern. This review critically examines the current evidence regarding the intricate relationship between diabetes and cognitive decline. It highlights the existing knowledge on the impact of diabetes on cognitive function, spanning from mild cognitive impairment to dementia, including vascular and Alzheimer dementia. The review underscores the need for a standardized diagnostic paradigm and explores research gaps, such as the implications of cognitive impairment in younger populations and various diabetes types. Furthermore, this review emphasizes the relevance of diabetes-related comorbidities, including hypertension and dyslipidemia, in influencing cognitive decline. It advocates for a comprehensive, interdisciplinary approach, integrating insights from neuroscience, endocrinology, and immunology to elucidate the mechanistic underpinnings of diabetes-related cognitive impairment. The second part of this review outlines prospective research directions and opportunities. It advocates for longitudinal studies to understand disease progression better and identifies critical windows of vulnerability. The search for accurate biomarkers and predictive factors is paramount, encompassing genetic and epigenetic considerations. Personalized approaches and tailored interventions are essential in addressing the substantial variability in cognitive outcomes among individuals with diabetes.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1097/md.0000000000035557
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
